Titlebook: Quantum Mechanics of One- and Two-Electron Atoms; Hans A. Bethe,Edwin E. Salpeter Book 1977 Plenum Publishing Corporation, New York 1977 Z

訓(xùn)誡

The helium atom without external fields,. equation for atoms having two electrons is

熱情的我

Atoms in external fields,We consider now the effect of an external magnetic field on single-electron atoms (with a . potential). We use, at the moment, CGS units instead of atomic units. We shall see that part of the effect of the magnetic field depends on the intrinsic spin, another part, connected with the orbital angular momentum, is independent of spin.

Ingrained

仔細(xì)檢查

Hans A. Bethe,Edwin E. SalpeterNA splicing in genetic diseases. In 2016, the US Food and Drug Administration (FDA)-approved Exondys 51 (eteplirsen) and Spinraza (nusinersen), the first exon skipping and exon inclusion drugs, to treat patients with Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA), respectively.

飾帶

Hans A. Bethe,Edwin E. Salpetertes and implementation advice from the experts.Includes suppThis volume explores experimental approaches used to study Duchenne muscular dystrophy (DMD), an X-linked degenerative skeletal muscle disease caused by mutations in the dystrophin gene. Including the latest progress and scientific achievem

獸群

Hans A. Bethe,Edwin E. Salpeteranges involve the entire genome expression pattern and heavily rely upon correlation patterns among genes. The classical approach used to analyze gene expression data builds upon the application of supervised statistical techniques to detect genes differentially expressed among two or more phenotype

insular

Hans A. Bethe,Edwin E. Salpetern the dystrophin (DMD) gene. Antisense oligonucleotides can be used to induce specific exon skipping; recently, a phosphorodiamidate morpholino oligomer (PMO) has been approved for clinical use in DMD. However, an efficient PMO delivery strategy is required to improve the therapeutic efficacy in DMD

波動(dòng)

Accolade

Ejaculate

asive breast cancer, the possible role of postmastectomy radiation for ductal carcinoma in situ (DCIS) remains unclear. Here, we examine the data that may be relevant to inform decisions regarding the potential indications, benefits, and side effects of postmastectomy radiation for DCIS, including d